Abstract Many mediators and regulators of extravasation by bona fide human memoryphenotype T cells remain undefined. Mucosal-associated invariant T (MAIT) cells are innate-like, antibacterial cells that we found excelled at crossing inflamed endothelium. They displayed abundant selectin ligands, with high expression of FUT7 and ST3GAL4, and expressed CCR6, CCR5, and CCR2, which played non-redundant roles in trafficking on activated endothelial cells. MAIT cells selectively expressed CCAAT/enhancer-binding protein delta (C/EBPd). Knockdown of C/EBPd diminished expression of FUT7, ST3GAL4 and CCR6, decreasing MAIT cell rolling and arrest, and consequently the cells' ability to cross an endothelial monolayer in vitro and extravasate in mice. Nonetheless, knockdown of C/EBPd did not affect CCR2, which was important for the step of transendothelial migration. Thus, MAIT cells demonstrate a program for extravasastion that includes, in part, C/EBPd and C/EBPd-regulated genes, and that could be used to enhance, or targeted to inhibit T cell recruitment into inflamed tissue.
Introduction
The phenotypes and functions of peripheral T cells are intimately linked to the cells' localization and patterns of migration (Masopust and Schenkel, 2013) . For memory-phenotype T cells, these relationships were the basis of the dichotomous schema describing central (T CM ) and effector (T EM ) memory cells (Sallusto et al., 1999) . The relationships among position, migration and function have also been emphasized in recent studies characterizing tissue resident memory T cells and recirculating memory T cells (Bromley et al., 2013; Fan and Rudensky, 2016; Gerlach et al., 2016; Masopust and Picker, 2012; Masopust and Schenkel, 2013) . Elegant experiments in mice have shown that resident memory T cells can have critical roles in protection at barrier sites (Jiang et al., 2012) . Less well defined have been the cells within the memory-phenotype population that can be recruited from the blood to an inflamed site in the very early stages of an immune response (Masopust and Picker, 2012) . Nonetheless, these 'first responders' can play essential roles in tissue defense (Kohlmeier et al., 2008; Maloy et al., 2000; Wakim et al., 2008) .
The recruitment of leukocytes to tissue from blood has been described within the longstanding paradigm, derived primarily from studies of neutrophils, of a multistep process of the cells' rolling, followed by arrest, crawling, and diapedesis (Ley et al., 2007 ). An abundance of data support roles for selectins and their ligands in rolling, and for stimulated chemoattractant receptors and consequent integrin activation in firm arrest and extravasation (Springer, 1994) . For trafficking of T EM cells to sites of inflammation, P-and E-selectins on endothelial cells and their glycosylated counterligands on T cells mediate rolling, which initiates the process (Ley and Kansas, 2004; Sperandio et al., 2009 ). The best characterized ligands for P-and E-selectin are proteins, such as PSGL-1 (mouse and human), CD43 (mouse and human), ESL-1(mouse), and CD44 (mouse) that bear sugars containing sialyl Lewis x (sLe x ), a tetrasaccharide consisting of N-acetylglucosamine, fucose, galactose, and sialic acid (Mondal et al., 2013; Phillips et al., 1990) . The ability of leukocytes to display selectin ligands is determined primarily by the expression of glycosyltransferases responsible for synthesizing the appropriate glycoforms. These enzymes include core 2 b1,6-N-acetylglucosaminyltransferases, a1,3-fucosyltransferases, and a2,3-sialyltransferases (Ley and Kansas, 2004; Sperandio et al., 2009) . Although the necessary enzymes and a full complement of selectin ligands are expressed constitutively on myeloid cells, expression on lymphocyte populations is heterogeneous and can be affected by cellular activation and differentiation (Austrup et al., 1997; Ley and Kansas, 2004; Wagers et al., 1998) . Studies of mouse CD4 + T cells and/or cell lines have shown high preferential expression of selectin ligands on Th1 versus Th2 cells (Austrup et al., 1997; Blander et al., 1999) , and counter-regulation of the a1,3-fucosyltransferase gene Fut7 by T-bet and GATA-3 (Chen et al., 2006) ; and Fut7 can be induced in mouse CD4 + T cells in response to a number of cytokines, including IL-12 and TGF-b1 (Ebel et al., 2015; Ebel and Kansas, 2016) . Little else is known about the molecular mechanisms regulating the expression of these glycosyltransferases in T cells. Selectin-mediated rolling allows leukocytes to sample the endothelium for seven-transmembrane domain receptor agonists, principally chemokines, and for ligands, such as VCAM-1, MAdCAM-1, and ICAM-1, for the a4b1, a4b7, and b2 integrins, respectively (Springer, 1994) . Although signals induced by selectin ligands on neutrophils can yield an integrin conformation sufficient to support integrin-mediated rolling (but not firm arrest), this is not observed for lymphocytes (Alon and Ley, 2008) . Moreover, except for integrins on recently activated/effector T cells (Shulman et al., 2011) , integrin activation that is sufficient to induce firm arrest under flow requires chemoattractant receptor-transduced signals (Alon and Ley, 2008) . Chemokine receptors not only induce integrin activation and leukocyte arrest, but also directly mediate transendothelial migration (TEM) (Cinamon et al., 2001; Shulman et al., 2011) . Among the 19 G-protein-coupled chemokine receptors, only two, CXCR4 and CCR7, are expressed on all naive T cells, whereas T cells with the eLife digest Lymphocytes are a type of cell found in the blood that can detect and fight infections: in particular, some of them can leave the bloodstream to enter infected or inflamed tissues. To do so, these lymphocytes use proteins on their surface to roll along the inside wall of the blood vessel; then they stick to this wall and finally they pass through it. For some types of lymphocytes the details of this mechanism -such as precisely which surface proteins are necessaryremain unclear.
Here, Lee et al. collect human lymphocytes from the blood of healthy donors, and they identify a subgroup of lymphocytes, called MAIT cells, that are particularly good at moving from blood to infected or inflamed tissues, and further experiments reveal the types of surface proteins that help them do so.
Some of these proteins, for example selectin ligands, are important so the MAIT cell can roll on the wall of the blood vessel. Others, like CCR6, are essential for the cell to stop rolling and stick to the wall. Lee et al. also identify C/EBPd, a regulatory protein inside the MAIT cell that controls how these other two types of proteins are produced. Finally, Lee et al. show that additional proteins, such as CCR2, are necessary for the lymphocyte to cross the vessel wall.
The proteins that help lymphocytes move from blood to tissues represent important targets to fight diseases. For example, blocking these proteins could prevent lymphocytes from invading and damaging healthy tissues, which happens in autoimmune diseases like multiple sclerosis. Alternatively, manipulating these proteins could help to engineer lymphocytes that can invade and kill tumor tissues in cancers.
effector/memory phenotype can express these and most of the remaining chemokine receptors, resulting in a high degree of combinatorial diversity (Bachelerie et al., 2014) . The expanded repertoire of chemokine receptors on these cells confers the potential to traffic to and within the wide range of inflammatory sites generated during host defense and injury. There is, however, relatively little understanding of how multiple chemokine receptors can cooperate to provide the functions required by specific T cell subsets, and how the expression of selectin ligands, chemokine receptors and integrins are co-regulated on memory-phenotype T cells in order to confer the ability to extravasate efficiently.
Within the migratory T cell population, the initial cells to enter inflamed tissue should share a T EM phenotype, including not only MHC class I/II restricted cells, but also innate-like T cell such as bloodborne subsets of g/d T cells (Hayday, 2000) , and mucosal-associated invariant T (MAIT) cells (Gapin, 2014) . In our previous studies, we characterized the subset of human CD4 + T cells coexpressing the chemokine receptors CCR5 and CCR2 (Zhang et al., 2010) . These cells also express multiple inflammation-associated chemokine receptors and have features of a stable population of highly differentiated cells well equipped to serve as early responding T EM . In extending these observations to CD8 + T cells, as described below, we found that most human CD8a + CCR2 + T cells were MAIT cells. MAIT cells are innate-like T cells that express Va7.2-Ja33 (TRAV1-2-TRAJ33 according to the IMGT/GENE-DB nomenclature (Giudicelli et al., 2005) as part of a semi-invariant TCR (Franciszkiewicz et al., 2016; Porcelli et al., 1993) , and recognize bacterial metabolites of riboflavin in the context of the non-polymorphic MR1 (Kjer-Nielsen et al., 2012) . Under homeostatic conditions, MAIT cells are found in the intestinal lamina propria and liver, and represent a significant percentage of CD8 + , memory-phenotype T cells in human blood. MAIT cells exhibit potent antibacterial activity and accumulate at sites of bacterial infections (Gold et al., 2010; Le Bourhis et al., 2010; Meierovics et al., 2013) . MAIT cells may also have roles in immune-mediated diseases (Hinks, 2016) . Although based on their expression of chemokine receptors and other surface markers, MAIT cells have been characterized as tissue-homing (Dusseaux et al., 2011) , there are no detailed studies of their trafficking behavior. Human MAIT cells have generally been identified by their co-expression of TCRVa7.2 and the NK cell marker CD161 (Franciszkiewicz et al., 2016) . The discovery of the MR1-bound ligands for the MAIT cell TCRs has allowed for the development of MR1 tetramers (Reantragoon et al., 2013) . Although these tetramers represent a significant new tool for studying MAIT cells, recent data show that the tetramers of MR1 bound to riboflavin-and folate-derived ligands can also identify a heterogeneous collection of Va7.2 -non-MAIT cells, thereby defining a broader population including both MAIT cells and 'atypical' Va7.2 -MR1-restricted T cells (Gherardin et al., 2016; Meermeier et al., 2016) . The vast majority of MAIT cells in human blood are CD8a + (many of which are also CD8b low ), and other than expression of CD8, no differences have been noted between CD8 + and CD8 -MAIT cells (Franciszkiewicz et al., 2016; Walker et al., 2012) . For the sake of brevity, because the work described below deals only with the MAIT cells that are CD8a + , we will use 'MAIT' in place of 'CD8a + MAIT'.
In our current work, we found that MAIT cells were highly efficient at extravasation across inflamed endothelium. We also discovered that MAIT cells selectively and highly express the bZIP transcription factor C/EBPd. siRNA-mediated knockdown of C/EBPd showed that C/EBPd contributed to the expression of glycosyltransferases/selectin ligands as well as CCR6 on MAIT cells, and consequently was required for optimal rolling and arrest of these cells on activated endothelial cells. Although these effects led to a decrease in the number of MAIT cells crossing the endothelium, knocking down C/EBPd had no separate effect on the final and critical step of transendothelial migration -which depended on CCR2. Taken together, our data show that MAIT cells are efficient at trafficking across inflamed endothelium due to a coordinated program, regulated in part by C/EBPd, that controls genes encoding proteins of disparate activities, each contributing to the migratory phenotype. Figure 2 -figure supplement 1A, below). In addition to CCR2, we found that MAIT cells also prominently expressed CXCR4, CXCR6, CCR5 and CCR6, but lacked CCR7 ( Figure 1B) , consistent with published data (Dusseaux et al., 2011) . CCR6 and CD161 are co-expressed on Th17 cells (Cosmi et al., 2008) , and we found that CCR6 and CD161 marked virtually identical cells within the CD8a + TCRVa7.2 + subset, so that CCR6 and CD161
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could be used interchangeably for identifying MAIT cells ( Figure 1C ). (Zhang et al., 2010) , and data from others identifying CCR5 and CCR2 as important receptors for TEM on effector/activated T cells (Shulman et al., 2011) , we considered whether MAIT cells -and in particular their CCR2 + subset -might exhibit efficient extravasation in the context of inflammation. We began the analysis using flow chamber assays with human umbilical vein endothelial cell (HUVEC) monolayers pre-treated overnight with TNFa.
For studying T-cell-endothelial cell interactions, we purified subsets of CD8a + T cells from peripheral blood using cell sorting, divided into MAIT cell and conventional cell subsets as described above and shown in Figure 2 -figure supplement 1A.
The staining with the anti-CCR2 antibody characteristically showed a continuum between CCR2 -and CCR2 + MAIT cells ( Figure 1A and Figure 2- Figure 2A ).
Although in our assays we detected TEM using differential interference contrast (DIC) microscopy, we were able to confirm that migration under the endothelial cell monolayer was occurring by using confocal microscopy with CFSE-stained CCR2 + MAIT cells and cell tracker Red CMTPX-stained 
CCR2 + MAIT cells traffic to inflamed tissue
In order to assess the ability of these subsets to traffic in vivo, we injected purified, CFSE-labeled cells into the left hearts of mice and, using flow cytometry, analyzed labeled cells remaining in inflamed (and non-inflamed) ears within a few minutes after injection. In these experiments, and some additional experiments that follow, the limitations in cell numbers discussed above prevented us from evaluating the CCR2 -/low MAIT subset. We detected retention of CCR2 + MAIT cells, but not cells from the other subsets, in ears that had had prior intradermal injection of TNFa and IL-1b ( Figure 2C ). We failed to detect any of these cells in non-inflamed ears. Confocal microscopy of ears after immuno-staining showed that labeled cells had extravasated into tissue ( Figure 2D and Video 2). The following source data and figure supplements are available for figure 2:
Source data 1. Data for Figure 2A Rolling correlates with levels of selectin ligands and glycosyltransferases
In order to understand the basis for the differences in rolling frequencies among the T-cell subsets, we analyzed adhesion molecules on the TNFa-treated HUVECs and the T cells. On the HUVECs, we detected up-regulation of E-, but not P-selectin, consistent with published data (Yao et al., 1996) , and up-regulation of both ICAM-1 and VCAM-1 ( Figure 3A) . Staining the T-cell subsets using E-selectin-Fc and P-selectinFc chimeric proteins showed a progressive increase in staining from naive to CCR6 À conventional to CCR6 + conventional to CCR2 -/low MAIT to CCR2 + MAIT cells ( Figure 3B) . A similar pattern was seen in staining the cells for sLe abolished rolling on TNFa-treated HUVECs ( Figure 3D ).
The differences in levels of selectin ligands among the T cell subsets could be due to differences in expression of the proteins that bear the relevant sugars and/or the degree of the appropriate glycosylation. Levels of surface PSGL-1 and CD43 could not explain the pattern of selectin ligand expression (Figure 3-figure supplement 1B). We also checked expression of CD44, even though CD44 has only been shown to be a selectin ligand on mouse neutrophils (Hidalgo et al., 2007; Mondal et al., 2013) . CD44 could also not account for the pattern of selectin ligand expression, although CD44 was found at somewhat higher levels on the CCR6 + subsets as compared with the naive and CCR6 -conventional cells. In general, expression of selectin ligands reflects regulation of the genes encoding the limiting glycosyltransferases (Ley and Kansas, 2004) . We found that patterns of expression of GCNT1, encoding core 2 b1,6-N-acetylglucosaminyltransferase-I, FUT4, FUT6, FUT9, ST3GAL1, 2, 3, and six were unremarkable ( Figure 3E and Figure 3 -figure supplement 1C). However, expression of FUT7 and ST3GAL4 were highest in the MAIT cells, and particularly in the CCR2 + MAIT cell subset ( Figure 3E ), consistent with the MAIT cells' high expression of selectin ligands and the important roles for FUT7 and ST3GAL4 in the synthesis of selectin ligands in leukocytes (Ellies et al., 2002; Malý et al., 1996; Mondal et al., 2015) .
CCR6 mediates firm arrest
Because leukocyte arrest on endothelium typically requires integrin activation in response to signals from chemoattractant receptors, we investigated the contributions of these two classes of proteins to the differences in the behaviors of the T cell subsets. As can be inferred from the expression patterns of integrin subunits ( Figure 4 -figure supplement 1), there were no differences in expression of LFA-1, VLA-4, and a 4 b 7 that could explain the differences in efficiencies of arrest among the subsets. To determine the overall role of chemokine receptors, which couple to G i/o G proteins, we analyzed T cells with and without pretreatment with pertussis toxin. Pertussis toxin had no effect on rolling, reduced the numbers of arrested memory- Figure 4A ). In order to focus on the chemokine receptors important for arrest and TEM of MAIT cells in the flow chambers, we analyzed the TNFa-treated endothelial cells for expression of the mRNAs for the chemokine ligands of the receptors highly expressed on the MAIT cells. TNFa induced high expression of the genes for the CCR2 ligand CCL2, the CCR5 ligand CCL5, and the CCR6 ligand CCL20, whereas CXCL16 was expressed at only a low level that was not augmented by TNFa ( Figure 4B ). We tested a role for CCR6 by using antibody to CCL20. Anti-CCL20 antibody significantly reduced numbers of cells arresting in the three CCR6 + subsets. Similarly, reflecting the effects specifically on the step of arresting, anti-CCL20 significantly reduced the percentage of rolling cells that arrested in two of the three CCR6 + subsets, but not in the CCR6 -cells ( Figure 4C ). Although convincing, the effects of anti-CCL20 were not large. It is notable in this regard that given the results using pertussis toxin, a 50% reduction in arresting cells is the maximum decrease that could have been expected by blocking a Ga i/o -coupled receptor such as CCR6. Our data did show statistically significant differences between control-and anti-CCL20-treated CCR2 + MAIT cells in numbers of cells rolling and percentages of arrested cells that underwent TEM.
Because similar results were not found for the other two CCR6-expressing subsets (CCR6 + conventional and CCR2 -/low MAIT cells), we concluded that CCR6 lacked a convincing activity in rolling or TEM of these cells. Taken together, the data suggest a role for CCR6 in arrest of the CCR6-expressing CD8a + memory-phenotype T cells, and little or no effects on the steps of rolling and TEM.
CCR2 mediates TEM and CCR5 shortens the time between arrest and TEM
We addressed the role of CCR2 in TEM by using the CCR2 antagonist, BMS CCR2 22. BMS CCR2 22 did not diminish the numbers of cells rolling or arrested -the lack of effect on firm arrest ruling out a general inhibition of chemokine receptor signaling. However, blocking CCR2 had a profound effect on TEM of the CCR2 + MAIT cells ( Figure 5A ). The CCR2 inhibitor also significantly diminished TEM of the CCR6 + conventional cells, consistent with the expression of CCR2 on a subset of these cells (Figure 2-figure supplement 1A) . The studies using the CCR2 inhibitor were among those experiments in which we did not include CCR2 -/low MAIT cells due to the low numbers of these cells that we could obtain from an individual donor. It is notable, however, that significant numbers of cells within the CCR2 -/low MAIT cell samples were able to undergo TEM ( Figure 2) . We presume that CCR2 expressed on the CCR2 low cells within these samples was responsible for this TEM.
Given the high expression of CCR5 by MAIT cells ( Figure 1B ) and expression of CCL5 by the TNFa-activated endothelial cells, we also investigated a role for CCR5 using the CCR5 antagonist, maraviroc. Blocking CCR5 had no effect on the numbers of cells rolling, arrested, or transmigrated ( Figure 5B ). However, among the transmigrating CCR2 + MAIT cells, blocking CCR5 significantly prolonged the time between when the cells initiated crawling and initiated TEM ( Figure 5C ). There was no effect on the time interval between arrest and initiating crawling. These data on the activity of CCR5 may partly explain the differences in time between arrest and TEM that we measured for the CCR6 
CCR6
+ conventional cells, we limited the analysis to cells that were CCR2 + because the data in Figure 5A indicated that the CCR2 + cells were those undergoing TEM, and therefore were the cells scored in Figure 2 -figure supplement 2C. For the CCR2 -/low MAIT cells, in addition to having levels of CCR5 that were lower than on the CCR2 + MAIT cells, the reduced expression of CCR2 presumably also contributed to their delay in initiating TEM.
C/EBPd regulates MAIT cell trafficking
Having determined some of the factors contributing to the trafficking behavior of MAIT cells, we next investigated how expression of these factors might be regulated. In previous, unpublished experiments we had characterized gene expression in the CCR5 + CCR2 + subset of CD4 + memoryphenotype T cells that we had studied earlier and discovered that these cells expressed high levels of CEBPD, which encodes C/EBPd. We found that MAIT cells also expressed high levels of CEBPD mRNA and C/EBPd, and that these could be knocked down using CEBPD siRNAs ( Figure 6A and B).
We found no selective expression in MAIT cells of the related genes CEBPA, CEBPB, CEBPE, CEBPG, and CEBPZ (Figure 6-figure supplement 1). siRNA-mediated knockdown of CEBPD diminished the overall trafficking of MAIT, but not non-MAIT cell subsets in the flow chamber assays ( Figure 6C ). Knockdown of C/EBPd had a significant effect on the rolling step ( Figure 6C ) and a modest, separate effect on firm arrest of the MAIT cells (percentage of rolling cells undergoing arrest), although the effect on the CCR2 + MAIT cell subset did not reach statistical significance ( Figure 6D ). Importantly, although knocking down C/EBPd diminished the numbers of MAIT cells crossing the activated endothelial cells through effects on the initial trafficking steps, knocking down C/EBPd had no consistent, independent effect on TEM (percentage of arrested cells undergoing TEM) in the MAIT cell subsets ( Figure 6D ). To evaluate a role for C/EBPd in trafficking in vivo, we co-injected differentially labeled CCR2 + MAIT cells that had been transfected with control or CEBPD siRNA into mice whose ears had been injected with TNFa and IL-1b. As compared to controls, significantly fewer cells with knockdown of C/EBPd could be recovered from the inflamed ears ( Figure 6E ).
C/EBPd regulates glycosyltransferases and CCR6
In order to understand the basis of the effects of knocking down C/EBPd on rolling and arrest, we investigated if knockdown of C/EBPd affected expression of sLe X /glycosyltransferases and chemokine receptors. Knockdown of C/EBPd decreased surface levels of sLe x and decreased expression of The following source data and figure supplements are available for figure 5:
Source data 1. Data for Figure 5A , B (flow chamber results for cells from individual experiments) and Figure Figure 7D) . In analyzing the effects of knocking down C/EBPd on chemokine receptors, we found that C/ EBPd supported the expression of surface CCR6 and CCR6 mRNA ( Figure 7E-G) . The 5' flanking region of CCR6 has multiple predicted binding sites for C/EBPd (Figure 7-figure supplement 2) , and just as for FUT7 and ST3GAL4, ChIP showed binding of C/EBPd to CCR6 ( Figure 7H) . Again, the effect of knocking down C/EBPd on the expression of CCR6 was limited to the MAIT cells, concordant with the pattern of C/EBPd expression.
Based on the absence of any effect of knocking down C/EBPd on MAIT cell TEM, we anticipated that knocking down C/EBPd would not affect expression of CCR2. As shown in Figure 7I , knocking down C/EBPd did not have a notable effect on the expression of either CCR2 or CCR5 in the MAIT cells.
Discussion
Our data demonstrate heterogeneous, graded expression of the components mediating extravasation into peripheral tissue within populations of human T cells. The abilities to roll, arrest and migrate across an inflamed endothelial cell layer are not all or none and reflect both qualitative and quantitative differences in expression of the essential components, with naïve and MAIT cells occupying extreme positions along a spectrum.
We found that the efficiency of the initial steps of rolling in the flow chamber assays were a function of the levels of surface selectin ligands and sLe x , which in turn correlated with expression of FUT7 and ST3GAL4. FucT-VII is the fucosyltransferase that is critical for synthesis of selectin ligands (Knibbs et al., 1996; Malý et al., 1996; Smithson et al., 2001 ). In particular, the level of FucT-VII is the determining factor in synthesis of E-selectin ligands (Knibbs et al., 1996; Ley and Kansas, 2004; Wagers et al., 1996) . The mouse and/or human genes for FucT-VII are induced in proliferating T cells (Blander et al., 1999; Knibbs et al., 1996) , up-regulated by IL-12 (Ebel et al., 2015; Wagers et al., 1998; White et al., 2001) , and suppressed by IL-4 (Wagers et al., 1998) , related to the activities of T-bet and GATA-3 (Chen et al., 2006) . Among sialyltransferases, ST3Gal-IV (Ellies et al., 2002; Sperandio et al., 2006) , together with ST3Gal-VI (Yang et al., 2012) , are the critical enzymes for synthesizing selectin ligands in mice, whereas ST3Gal-IV is the dominant sialyltransferase in synthesizing selectin ligands on myeloid cells in humans (Mondal et al., 2015) . Like the mouse Fut7 and/or human FUT7, St3gal4 is induced by T cell activation (Blander et al., 1999) . However, little is known about how the mouse or human gene for ST3Gal-IV is regulated.
In concert with the progressive increase that we found among the memory-phenotype T cell subsets in levels of selectin ligands and rolling, we found enhanced abilities for firm arrest that could not be explained by differences in integrin expression. Antibody neutralization of the CCR6 ligand, CCL20, resulted in decreased numbers of cells arresting in flow chambers. Our findings are consistent with reports describing the ability of CCR6 to mediate arrest of lymphocytes, including, very recently, MAIT cells on adhesion-molecule coated plates and/or activated endothelial cells (Alcaide et al., 2012; Campbell et al., 1998; Fitzhugh et al., 2000; Ghannam et al., 2011; Kim et al., 2017) . Of particular interest, the other chemokine receptors on the CD8a + T cells could not substitute for CCR6 in maintaining optimal firm arrest, nor was CCR6/CCL20 necessary for TEM of those cells showing CCR6-independent arrest. On the CD8a + T cells, therefore, CCR6 has a particular role in triggering firm arrest. CCR6 is notable as the chemokine receptor that is expressed on all T cells that can make IL-17 (Acosta- Rodriguez et al., 2007; Singh et al., 2008) , and CCR6 has been shown to be important for Th17 cell arrest on ICAM-1 (Alcaide et al., 2012) . In addition to the Th17 cell regulator RORgt, only STAT5A (Tsuruyama et al., 2016) and, from our own work, PLZF (Singh et al., 2015) have been described as controlling CCR6. Based on our experiments using siRNA knockdown and ChIP, we have now identified C/EBPd as an additional, direct activator of CCR6.
The pertussis-toxin resistant arrest that we observed in the memory-phenotype T cell subsets could be viewed as a 'baseline' activity on which inducible integrin activation can be superimposed. Although we are not aware of pertussis-toxin resistant arrest being reported previously for resting memory-phenotype cells, this phenomenon has been described for human effector T cells produced by activation ex vivo (Shulman et al., 2011) . For those cells, unlike for the CCR6 + CD8a + memoryphenotype T cells, there was no pertussis toxin sensitive component to the firm arrest, and their behavior was ascribed to high levels of integrin expression together with constitutive activity of PLCg1 (Shulman et al., 2011) . Non-integrin mediated adhesion is another possibility (SchneiderHohendorf et al., 2014). We have not investigated the mechanism responsible for the pertussis toxin resistant component of arrest by these resting cells, but our data suggest that in this regard the memory-phenotype CD8a + T cells occupy a position intermediate between naïve and activated effector cells. We found that blocking CCR5 did not affect the T cells' arrest, nor did it prevent cells from undergoing TEM over the 20 min of observation. However, the data indicated that CCR5 functioned to shorten the time between the initiation of crawling and TEM, which, in vivo, would be presumed to speed extravasation. Consistent with our observations, CCR5 has been found not to contribute to leukocyte adhesion, either in flow chambers or in blood vessels (Diacovo et al., 2005 ; Shulman et al., 2011; Weber et al., 2001) , but nonetheless to have roles in completing the process of extravasation (Diacovo et al., 2005) . For CCR2, our data showed a critical and specific role in TEM. We often observed significant TEM not only in the CCR2 + MAIT cells, but also in the CCR2 -/low MAIT cells. We presume that the CCR2 low MAIT cells within the CCR2 -/low MAIT cell samples accounted for the ability of cells in these samples to perform TEM. Because the number of CCR2 -/low MAIT cells that we obtained from an individual donor was often inadequate for the flow chamber studies, thereby limiting the number of studies that we could do with these cells, we have not used the CCR2 antagonist to test the possibility that CCR2 was mediating TEM in the CCR2 -/low cells.
Although CCR2 has been studied extensively in monocyte biology, relatively little is known about the role of CCR2 on T cells. It is of interest that on monocytes, CCR2 and CCL2 were also described as important for TEM (Weber et al., 1999) , but not for firm adhesion (Huo et al., 2001; Weber et al., 1999) . Of particular relevance for our studies, CCR2 was reported to be essential for TEM across HUVECs and human dermal microvascular endothelial cells in experiments using a mixed population of activated T cells (Shulman et al., 2011) . We have previously shown that CCR2 is expressed on a subset of human CCR5 + CD4 + T cells that have features of a stable population of highly differentiated long-term memory cells which, based on chemokine receptor expression, TCR activation threshold, and effector cytokine production, are ideally equipped for mediating rapid recall responses in tissue (Zhang et al., 2010) . In addition, CD4 + CCR5 + CCR2 + T cells are found in cerebrospinal fluid associated with episodes of relapse in multiple sclerosis, and these cells demonstrate an enhanced ability to migrate across a model of the blood-brain barrier (Sato et al., 2012) . Recent data in mice have suggested that CCR2 is important for the trafficking into the CNS of a pathological subset of Th17 cells that contributes to chronic and relapsing EAE (Kara et al., 2015) . Taken together, the data suggest that -unlike for some other chemokine receptors that are associated with individual Th cell lineages -up-regulation of CCR2 (and CCR5) is part of a program directed specifically at conferring the capacity for migration of T cells into tissue. Given the high degree of ligand/receptor promiscuity, the co-expression of many chemokines during inflammation, the co-expression of multiple chemokine receptors on individual cells, and the shared pathways for chemokine receptor signaling, studies of the chemokine system have often confronted questions of functional redundancy. Our data suggest that CCR6, CCR5, and CCR2 serve sequential and distinct functions in MAIT cell extravasation. From our experiments using anti-CCL20 antibodies, we can conclude that CCL20 is displayed on the surface of the TNFa-treated endothelial cells, and from the work of Shulman et al. (2011) , we know that CCL2 is sequestered in endothelial cell vesicles and only available to CCR2 within T-cell-endothelial cell synapses. Taken together, these observations suggest that the separate roles for the receptors could be the result of anatomic segregation of their chemokine ligands, which might be a general feature of the chemokine system that limits functional redundancy.
Our interest in understanding the relationships between the expression of chemokine receptors such as CCR6 and CCR2 and the biology of T cell subsets led us to these studies of MAIT cells and their trafficking behavior. Our and/or others' data (Dusseaux et al., 2011; Kim et al., 2017) showed that the MAIT cells were at the high end of a continuum among CD8a + T cells as regards expression of selectin ligands and/or multiple tissue-homing chemokine receptors, and at the low end of a continuum as regards expression of CCR7 and CD62L, which are required for entering non-inflamed lymph nodes. The MAIT cells' behavior on activated endothelial cells in the flow chamber assays and in vivo were fully consistent with an enhanced ability to enter inflamed tissue rapidly, without additional phenotypic changes and/or activation within lymphoid organs. MAIT cells are able to make effector cytokines, and they contain cytotoxic molecules such as perforin, granulysin and granzymes (Dusseaux et al., 2011; Franciszkiewicz et al., 2016; Le Bourhis et al., 2013) . MAIT cells are able to produce effector cytokines both in response to TCR activation and directly in response to cytokines such as IL-18 and IL-12 (Franciszkiewicz et al., 2016; Jo et al., 2014; Slichter et al., 2016; Ussher et al., 2014) . These properties would allow MAIT cells to function locally within the earliest stages of antibacterial, and perhaps antiviral (Loh et al., 2016; van Wilgenburg et al., 2016) defense. In support of such a role, MAIT cells are decreased in blood of patients with bacterial pneumonias, and can be identified in M. tuberculosis-infected lungs (Le Bourhis et al., 2010) .
We found that in MAIT cells, both FUT7 and ST3GAL4, as well as CCR6, are regulated in part by C/EBPd, and our ChIP data suggest that FUT7, ST3GAL4, and CCR6 are direct targets of C/EBPd. Knockdown of C/EBPd resulted in decreased surface expression of both sLe x and CCR6, although the resulting effects on numbers of rolling cells mediated by selectin ligands was more pronounced than on the specific step of firm arrest mediated in part by CCR6. Since the multiple steps of extravasation occur sequentially and interdependently, C/EBPd's regulation of rolling and firm arrest significantly affected numbers of cells migrating across the activated endothelial cells in the flow chamber assays. We presume that the effects that we documented in the flow chamber assays were the basis for the decreased entry of MAIT cells transfected with CEBPD siRNA into inflamed ears. We have summarized our findings for CCR2-expressing MAIT cells in the cartoon shown in Video 3. Knockdown of C/EBPd had no independent effect on the final step of MAIT cell TEM in the flow chamber assays, nor, consistent with this finding, on expression of CCR2 (or CCR5). Nonetheless, it is of interest that Yamamoto et al. described C/EBP binding sites 3' to the CCR2 transcriptional start site that were important for CCR2 promoter activity and that could bind C/EBP proteins, including C/EBPd, found in nuclear extracts of a human monocytic cell line (Yamamoto et al., 1999) . These data suggest that our negative results notwithstanding, C/EBPd might, in fact, have a role in regulating CCR2 expression in MAIT cells. Regardless, consideration of these data raises the important point that experiments using siRNA knockdown will typically underestimate roles of target genes given that mRNA and protein knockdown are incomplete both at the level of individual cells and across the heterogeneous population of siRNA-transfected cells. Consequently, our findings using siRNA knockdown of C/EBPd reflect the lower limit of the activities of C/EBPd in supporting expression of the glycosyltransferases and CCR6, and thereby MAIT cell trafficking.
We attributed the effect of knocking down C/EBPd on the step of firm arrest to the decrease in expression of CCR6. Nonetheless, it is of interest that studies in mice have shown that ST3Gal-IV sialylates CXCR2 (Frommhold et al., 2008) , and probably CCR1, and CCR5 (although not CCR2) (Dö ring et al., 2014) . For these receptors, sialylation is important for chemokine-dependent activation. There is no evidence for sialylation of CCR6, but it remains possible that in addition to a decrease in expression of CCR6, knockdown of C/EBPd could have led to diminished CCR6 function through loss of ST3Gal-IV-dependent sialylation. A role for glycosylation in CCR6 function warrants further study. C/EBPd is one of six members of the C/EBP family of bZIP transcription factors, each of which contains a basic DNA-binding domain and a 'leucine zipper' dimerization domain (Ramji and Foka, 2002) . In mice, Cebpd is induced in many tissues in response to endotoxin or other inflammatory stimuli, including cytokines such as IL-6 and IL-1, although expression in these contexts is typically transient (Alam et al., 1992; Ko et al., 2015) . Studies in Cebpd knockout mice have demonstrated pleiotropic roles for C/EBPd, including in multiple models of inflammation and infection Chang et al., 2012; Duitman et al., 2012; Litvak et al., 2009) . C/EBPd has been implicated in the acute phase response (Alam et al., 1992; Juan et al., 1993; Ray and Ray, 1994) and in the phenotype and function of macrophages Chang et al., 2012; Duitman et al., 2012; Litvak et al., 2009; Maitra et al., 2011; Yan et al., 2013; Litvak et al., 2009; Maitra et al., 2011; . Of possible relevance to our own work, C/EBPd has been suggested to enhance the migration of macrophages into infected lung (Duitman et al., 2012) . A broader role for C/EBPd in regulating leukocyte migration in inflammation is suggested by data on the C/EBPd-mediated induction of chemokines, including the ligands for CCR6 (Chang et al., 2012) and CCR2 (Ko et al., 2014) , and in the transcriptional response of endothelial cells to inflammatory stimuli Video 3. Summary cartoon, C/EBPd blocks early steps in MAIT cell trafficking. DOI: https://doi.org/10.7554/eLife.32532.033 (Hogan et al., 2017) . In T cells, expression of CEBPD was detected in analyzing the transcriptome of human CD8 + CD161 + T cells (Billerbeck et al., 2010) , which would have included MAIT cells, and a bioinformatic analysis of the transcriptome and epigenetic modifications of human CD4 + T cells suggested that C/EBPd might function as one of the 'master regulators' of T EM differentiation (Durek et al., 2016) . However, as far as we are aware, functional studies of C/EBPd in T cells have not been previously reported. Another transcription factor that has been described with an effect that is analogous but functionally inverse to C/EBPd is Kruppel-like factor 2 (KLF2), which supports T cell trafficking to lymph nodes versus peripheral tissue by enhancing expression of CD62L and CCR7, and suppressing CXCR3 (Carlson et al., 2006; Preston et al., 2013) . Similarly, SOCS1-mediated inhibition of STATs favors T cell trafficking to lymphoid organs versus peripheral tissue by enhancing expression of CCR7 and suppressing expression of CCR6 and CXCR3 (Yu et al., 2008) . Based on our data, in contrast to these other factors, C/EBPd is a positive regulator supporting the tissue-migrating phenotype.
Our study has some clear limitations that affect the generalizability of our conclusions. We studied only human MAIT cells from blood. Our ex vivo experiments used only a single type of endothelial cell (HUVEC) treated with a single pro-inflammatory activator (TNFa), and our in vivo experiments were limited to a simple and artificial model of inflammation at a single tissue site. It is possible that other endothelial cells and/or other activators would differentially affect the abilities of MAIT and non-MAIT cells to arrest and undergo TEM, and thereby reveal activities of other molecules, such as additional transcription factors and chemokine receptors, in these processes. Studies extended to more complex animal models would provide information on the performance of MAIT cells and the molecular mechanisms underlying their trafficking behavior in more biologically relevant models of inflammation. It will be of considerable interest to identify additional factors that control the program for extravasation and the interactions among overlapping networks specifying this activity in coordination with the fates and functions of effector-capable T cells. An understanding of the molecular species regulating the integration of migratory activity and other effector functions of such cells would suggest ways of enhancing or inhibiting T-cell mediated processes in peripheral tissues. Mice C57BL/6J WT mice were purchased from The Jackson Laboratory (Bar Harbor, ME). All mice were used at 8-12 weeks of age. Mice were housed under specific pathogen-free conditions at the National Institutes of Health in an American Association for the Accreditation of Laboratory Animal Care-approved facility. Animal study protocols were approved by the Animal Care and Use Committee, NIAID, NIH.
Materials and methods

Key resources table
Antibodies and selectin-Fc fusion proteins
All antibodies were against human antigens. Anti-CCR2-biotin (clone 48607), anti-PSGL-1-allophycocyanin (688101), human E-selctin Fc chimera and human P-selectin Fc chimera were purchased from R and D Systems, Minneapolis, MN. Anti-CCR5-FITC (2D7), anti-CCR5-PE-Cy5, anti-CCR4-Alexa Fluor 647 (1G1), anti-CCR7-FITC (3D12), anti-CCR9-Alexa Fluor 488 (112509), anti-CCR10-PE (1B5), anti-CXCR1-FITC (5A12), anti-CXCR2-allophycocyanin (6C6), anti-CXCR3-allophycocyanin (1C6), anti-CXCR4-allophycocyanin (12G5), anti-CXCR5-Alexa Fluor 647 (RF8B2), anti-CD8-APC-Cy7 (SK1), anti-CD8-Alexa Fluor 700 (RPA-T8), anti-CD62L-PE-Cy5 (DREG-56), anti-CD62L-FITC, anti-CD45RO-PE-Cy5 (UCHL1), anti-CD45RO-Brilliant Violet 605, anti-CD45RO-PE-Cy7, anti-CCR6-PECy7 (11A9), anti-CCR6-allophycocyanin, non-conjugated anti-sLe X (CSLEX1), anti-CD161-allophycocyanin (DX12), and PE-conjugated streptavidin were purchased from BD Biosciences, Franklin Lakes, NJ. Anti-integrin a4-FITC (58XB4), anti-integrin b1-Alexa Fluor 647 (TS2/16), anti-integrin b2-allophycocyanin (TS1/18), anti-integrin b7-allophycocyanin (FIB504), anti-TCRV a 7.2-FITC (3C10), anti-CXCR6-PE (K041E5), anti-CX3CR1-FITC (2A9-1), anti-CD43-allophycocyanin (10G7), anti-CD44-allophycocyanin (BJ18) and anti-human IgG Fc-biotin were purchased from BioLegend, San Diego, CA.
Flow cytometry
For phenotypic analysis of leukocyte subsets, cells were stained in whole blood, in preparations of PBMCs isolated from blood using Ficoll/Hypaque (Amersham Biosciences, United Kingdom), or in preparations of CD8 + T cells purified from elutriated lymphocytes by negative selection using RosetteSep (StemCell Technologies, Canada). For whole blood samples, red cells were removed using Pharm Lyse (BD Biosciences) according to the manufacturer's protocol. For staining other samples, 1 Â 10 5 cells were suspended in 100 ml of Hanks Balanced Salt Solution (HBSS, Mediatech, Corning, NY) containing 2% FBS. For each sample, cells were incubated with 1 mg of each fluorescent-conjugated primary antibody for 15 min at room temperature (RT), and washed with HBSS/FBS. For cells stained with anti-CCR2-biotin, the cells were incubated with PE-conjugated streptavidin for an additional 15 min at RT. For staining sLe X , the cells were incubated with allophycocyanin-conjugated anti mouse IgM (II/41) (BD Biosciences) for an additional 15 min at RT. For staining with E-selectin Fc chimera or P-selectin Fc chimera, the chimeric proteins were first incubated with anti-human IgG Fc-biotin in 100 ml binding buffer (HBSS +5 mM calcium chloride +2 mg/ ml BSA) on ice for 10 min before cells were added and incubated on ice for 30 min. After washing with chilled binding buffer, the cells were incubated with streptavidin-PE on ice for 10 min before being washed and analyzed. Staining data were collected on an LSR II cytometer (BD Biosciences).
To set gates for defining positive and negative cells in multicolor staining, samples were stained with a mixture of all antibodies save one. Flow cytometry data were analyzed using FlowJo (Ashland, OR).
Cell sorting Approximately 1.5 Â 10 8 CD8 + T cells were isolated from elutriated lymphocytes to approximately 90% purity by negative selection using RosetteSep human CD8 + T cell enrichment cocktail (StemCell Technologies) and incubated with anti-CCR2-biotin and anti-CCR6-PE-Cy7 in HBSS plus 4% FBS for 15 min at RT. Following washing, the cells were stained with streptavidin-PE, anti-CD8-Alexa 700, anti-TCRVa7.2-FITC, anti-CD62L-PE-Cy5, and anti-CD45RO-Brilliant Violet 605 for an additional 15 min at RT. The cells were washed and re-suspended in HBSS plus 4% FBS, and cell subsets were isolated to nearly 100% purity using an Aria cytometer (BD Biosciences).
Analysis of CD8a + T cell migration under flow
HUVECs were plated at confluence on m-Slide I 0.4 Luer parallel plate flow chambers (Ibidi, LLC, Germany) which were coated with 50 mg/ml fibronectin (R and D Systems) in PBS, and were stimulated for 18-20 hr with human recombinant TNFa (40 ng/ml (R and D Systems). HUVEC-coated parallel plate flow chambers were assembled with a two-pump system (Harvard Apparatus, Holliston, MA). Sorted T cells were re-suspended at 4 Â 10 5 cells/ml in perfusion medium (RPMI 1640 medium containing 2% FBS and 10 mM HEPES 
T cell trafficking in vivo
Inflammation was induced in the ears of C57BL/6 mice by intradermal injection of murine TNFa (10 mg (R and D Systems) and IL-1b (1 mg (R and D Systems) in 20 ml PBS. Eighteen hours after injection, 1 Â 10 6 human T cells were injected into the left ventricle, and mice were euthanized 8 min later.
Ears were removed, ear sheets were split and cartilage and fat were scraped off. The sheets were then immediately fixed in cold acetone for 20 min for tissue staining or treated in DMEM (Invitrogen, Carlsbad, CA) containing 1 mg/ml DNase I (Sigma-Aldrich St. Louis, MO) and 250 mg/ml Liberase TM (Roche Custombiotech, Indianapolis, IN) for 50 min at 37˚C to obtain cell suspensions. Cells were then filtered through a 70 mm nylon mesh and washed prior to counting using the flow cytometer. In some cases, the T cells were labeled with either CMTPX (Life Technologies) or CFSE (Life Technologies) prior to injection.
Immunofluorescence microscopy
Staining for human CD3, and murine CD31 was done using acetone-fixed ear skin sheets. Skin sheets were blocked for 2 hr at RT with Fc-blocker (BD Biosciences) in PBS containing 4% bovine serum albumin (Sigma-Aldrich). After washing in PBS, skin sheets were incubated with anti-mouse CD31-Alexa Fluor 647 and anti-human CD3-Brilliant Violet 605 antibodies (BioLegend) overnight at 4˚C. After washing in PBS, the sections were incubated with DAPI nuclear stain (Invitrogen). Images were acquired using the Carl Zeiss LSM510/Axio Observer confocal microscope and LSM510 version 4.2 software.
Treatments with sialidase, inhibitors, and neutralizing antibody in flow chamber assays
For removing sialic acid residues, cell-sorted subsets of CD8 + T cells were treated with 0.1 units of sialidase (from Vibrio cholera, Sigma-Aldrich) in 1 ml RPMI 1640 (Life Technologies) containing 10% FBS (Gemini Bio-Products) and 2 mM L-glutamine for 2.5 hr at 37˚C. For inhibiting G i/o proteins, CD8 + T cells were pre-incubated with pertussis toxin (1 mg/ml (R and D Systems) in RPMI 1640 medium containing 10% FBS and 10 mM HEPES for 3 hr at 37˚C. For blocking CCR2 and CCR5, preincubation was with BMS CCR2 22 (2 mM (Tocris, Minneapolis, MN) or Maraviroc (10 mM (Tocris), respectively, for 30 min at 37˚C and inhibitors were left in the medium throughout the assay. For neutralizing CCL20, HUVEC monolayers in flow chambers were pre-treated for 2 hr at 37˚C with 20 mg/ml anti-human CCL20/MIP-3a antibody (c67310; R and D Systems), and antibody was maintained at 10 ng/ml throughout the assay.
Total RNA isolation and real-time RT-PCR Subsets of CD8 + T cells were purified by cell sorting as described above. Total cellular RNA was isolated using the TRIzol reagent (Invitrogen). Real-time RT-PCR was performed with 20 ng of RNA as a template, using the qScript cDNA SuperMix for reverse transcription and PerfeCTa qPCR FastMix, UNG, and ROX for PCR (Quanta Biosciences, Beverly, MA). Primer and probe sets (FAM/VIClabeled) were purchased from Applied Biosystems, Foster City, CA. Results were normalized based on the values for GAPDH, detected using TaqMan GAPDH control reagents (Applied Biosystems). Real-time qPCR analysis was performed on samples in duplicate using an ABI 7700 Sequence Detection System (Applied Biosystems). For some assays, for cells from each donor, relative levels of expression, based on values for 2 ÀDCT , are shown after normalization to the single highest value, which was set to 100. For other assays, values of 2 ÀDCT are shown without additional normalization.
siRNA transfection
Transfections with Amaxa Human T Cell Nucleofector Kit (Lonza, Walkersville, MD) and siRNAs (Dharmacon, Lafayette, CO) were performed following the manufacturers' protocols (Lonza). Five nmol of SMARTpool, SMARTpool control, or individual siRNAs was reconstituted in 250 ml of siRNA buffer, and a total of 10-20 ml was added to a cuvette containing 2-4 Â 10 6 purified human CD8 + T cells in 100 ml transfection reaction buffer (prepared from Nucleofector Solution and Supplement). The cuvette with cell/siRNA suspension was inserted into the Nucleofector Cuvette Holder and subjected to Nucleofector Program V-024. Five hundred ml of pre-equilibrated culture medium (RPMI 1640 containing 10% FBS, 2 mM L-glutamine, and penicillin-streptomycin) was added to the cuvette, the sample was transferred to the well of 12-well plate, and culture medium was added to a total volume of 2 ml/well. Cells were incubated for 3-4 days at 37˚C in 5% CO 2 . 
Western blotting
Subsets of CD8 + T cells were purified by cell sorting as described above and lysed on ice in buffer (30 mM Tris HCl, pH 8.0; 75 mM NaCl; 10% glycerol; and 1% Triton X-100) containing 1:100 proteinase inhibitor cocktail (Cell Signaling, Danvers, MA). Cellular lysates were centrifuged at 12,000 x g for 10 min at 4˚C, and supernatants were collected after centrifugation. Protein content was quantified using the Micro BCA protein assay (Pierce, Rockford, lL) according to the manufacturer's guidelines with BSA as a standard. Samples were prepared for SDS-PAGE by boiling at 100˚C with 2 x Laemmli sample buffer (Bio-Rad, Hercules, CA) plus 5% b-Mercaptoenthol. A total of 40 mg of cellular proteins and an aliquot of the PageRuler Plus Prestained Protein Ladder (Thermo Scientific, Waltham, MA) were separted by SDS-PAGE in Any kD Mini-PROTEAN TGX Gel (Bio-Rad) at 100 V. After electrophoresis, protein was transferred to an Immun-Blot polyvinylidene difluoride membrane (Bio-Rad) over 1 hr at RT, using a Mini Trans-Blot Cell (Bio-Rad). Following transfer, the membrane was washed in Tris-buffered saline (20 mM Tris, 136 mM NaCl, PH 7.4) with 0.1% Tween 20 (TBST), blocked for 1 hr in TBST/5% nonfat dried milk, incubated overnight at 4˚C in the same solution containing 1:10,000 dilution of mouse anti-human C/EBPd, washed with TBST and incubated at RT with 1:10,000 dilution of HRP-conjugated sheep anti-mouse antibody (GE Healthcare, United Kingdom) in TBST/5% nonfat dried milk for 1 hr, and then washed with TBST at RT. Protein bands were visualized using SuperSignal West Pico Chemiluminescent Substrate (Pierce). Anti-human C/ EBPd was a kind gift from Esta Sterneck, NCI, NIH. Quantification of bands was done using Adobe Photoshop (San Jose, CA) and the ImageJ (NIH) program as described on the following web site: https://www.lukemiller.org/journal/2007/08/quantifying-Western-blots-without.html
Chromatin immunoprecipitation and quantification of immunoprecipiated DNA
ChIP experiments were performed using Magna ChIP A/G kit from Millipore, Burlington, MA, according to the manufacturer's instruction. Sorted cells were subjected to protein-DNA crosslinking with 1% formaldehyde for 10 min at RT and the reaction was terminated by addition of glycine solution to a final concentration of 125 mM. Cells were re-suspended in cell lysis buffer containing protease inhibitor cocktail. Samples were centrifuged at 2000 rpm for 5 min at 4˚C, and the cell pellet was re-suspended in nuclear lysis buffer containing protease inhibitor cocktail. Chromatin was sheared by Bioruptor sonicator (Diagenode, Denville, NJ) to generate DNA fragments between 200 and 1000 base pairs, centrifuged at 13,000 rpm for 10 min at 4˚C to pellet debris and diluted 10-fold in ChIP dilution buffer containing protease inhibitor cocktail. After removing 1% of the sample for analyzing input DNA, the sheared chromatin was incubated at 4˚C overnight under rotation with protein A/G magnetic beads and rabbit polyclonal anti-C/EBPd (Santa Cruz Biotechnology, Dallas, TX) or normal rabbit IgG as a negative control (Millipore), or mouse monoclonal anti-C/EBPd (C6, Santa Cruz Biotechnology) or normal mouse IgG as a negative control (Millipore). The immunoprecipitates were washed sequentially for 5 min with low-salt immune complex wash buffer, high salt immune complex wash buffer, LiCl immune complex wash buffer and TE buffer. The protein A/G magnetic beads/antibody/chromatin complex was re-suspended in 100 ml of ChIP elution buffer containing 1 ml proteinase K. The crosslinking between DNA and proteins was reversed by incubating the sample at 62˚C for 2 hr followed by 95˚C for 10 min. DNA was purified by spin column. To analyze promoter regions of CCR6, FUT7 and ST3GAL4, we used primers at 1 kb intervals as noted in the legend for Figure 7 . Quantitative real-time PCR was performed on an Applied Biosystems 7900HT system to determine the relative abundance of target DNA using RT 2 SYBR Green/ROX qPCR master mix according to the manufacturer's instructions (SA Biosciences, Frederick, MD). A ChIP PCR primer from IGX1A targeting open-reading-frame-free intergenic DNA (SA Biosciences) was used as a negative control. The percent input enrichment was calculated using ChIP PCR array data analysis software (SA Biosciences).
Computational prediction of C/EBPd binding sites
The positions of possible transcription factor binding sites (TFBS) in relevant genes were identified in a 20,000 bp region immediately upstream of the transcription start sites (TSS) using the Genomatix Genome Analyzer's Common TF software (Ann Arbor, MI) with default settings. The input sequences were manually obtained from the February 2009 human reference sequence (GRCh37/hg19) in FASTA format. An optimized CEBPD-binding weight matrix was constructed based on known binding sites.
Experimental design and statistical analysis
Sample sizes were chosen based on pilot experiments, and took into consideration the nature of the measurements being made, the magnitudes of differences among groups being compared, and the degrees of donor-to-donor variability. No explicit power analyses were used. In some experiments a minimum of six experiments were performed in order to satisfy the requirements of the Wilcoxon signed rank test. Sample identities were not routinely masked during data acquisition or analysis.
Most experimental results were replicated by two investigators. In some cases, only data from one investigator are shown. Otherwise, experiments were excluded only in cases of technical problems that made the results uninformative. We did not define or exclude outliers. Numbers of experimental replicates are noted in the figure legends, and refer to independent experiments and not technical replicates. Given the low abundance of some of the T cells subsets that were studied, most experiments contained a single measurement made for a single sample from a single donor. All statistical tests were performed on directed pairwise comparisons. The tests included two-tailed t tests that were either paired, ratio paired, or unpaired, and the Wilcoxon signed rank test. SEMs are shown for the raw data that were analyzed using the t tests. For some experiments that included control and treated samples, the paired t test was used in place of the ratio paired t test due to the presence of values equal to 0. Tests used for each data set are noted in the figure legends and the source files. No corrections were made for multiple comparisons. Significance is displayed as *p<0.05; **p<0.01; ***p<0.001. Statistical analyses were done using Prism (GraphPad, La Jolla, CA).
